Intranasal Oxytocin in Hypothalamic Obesity
Conditions: Craniopharyngioma; Hypothalamic Obesity Interventions: Drug: Syntocinon; Drug: Placebo (for Syntocinon) Sponsor: Shana McCormack, MD Not yet recruiting - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials